İ. ÇALIK Et Al. , "LP44 (4-[2-(methylthio)phenyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide) exerts anti-ulcer effects via 5-hydroxytryptamine receptor 7 activation on indomethacin-induced gastric ulcers in rats," INFLAMMOPHARMACOLOGY , vol.28, no.4, pp.893-902, 2020
ÇALIK, İ. Et Al. 2020. LP44 (4-[2-(methylthio)phenyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide) exerts anti-ulcer effects via 5-hydroxytryptamine receptor 7 activation on indomethacin-induced gastric ulcers in rats. INFLAMMOPHARMACOLOGY , vol.28, no.4 , 893-902.
ÇALIK, İ., YAYLA, M., Cinar, I., ÇADIRCI, E., ALBAYRAK, A., Sirin, B., ... ÇALIK, M.(2020). LP44 (4-[2-(methylthio)phenyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide) exerts anti-ulcer effects via 5-hydroxytryptamine receptor 7 activation on indomethacin-induced gastric ulcers in rats. INFLAMMOPHARMACOLOGY , vol.28, no.4, 893-902.
ÇALIK, İLKNUR Et Al. "LP44 (4-[2-(methylthio)phenyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide) exerts anti-ulcer effects via 5-hydroxytryptamine receptor 7 activation on indomethacin-induced gastric ulcers in rats," INFLAMMOPHARMACOLOGY , vol.28, no.4, 893-902, 2020
ÇALIK, İLKNUR Et Al. "LP44 (4-[2-(methylthio)phenyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide) exerts anti-ulcer effects via 5-hydroxytryptamine receptor 7 activation on indomethacin-induced gastric ulcers in rats." INFLAMMOPHARMACOLOGY , vol.28, no.4, pp.893-902, 2020
ÇALIK, İ. Et Al. (2020) . "LP44 (4-[2-(methylthio)phenyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide) exerts anti-ulcer effects via 5-hydroxytryptamine receptor 7 activation on indomethacin-induced gastric ulcers in rats." INFLAMMOPHARMACOLOGY , vol.28, no.4, pp.893-902.
@article{article, author={İLKNUR ÇALIK Et Al. }, title={LP44 (4-[2-(methylthio)phenyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide) exerts anti-ulcer effects via 5-hydroxytryptamine receptor 7 activation on indomethacin-induced gastric ulcers in rats}, journal={INFLAMMOPHARMACOLOGY}, year=2020, pages={893-902} }